Cell published peer-reviewed research on July 24, 2026, establishing that human CNNM4 uses a dynamic dimer-of-dimers architecture to manage magnesium ion transport. The study identifies this dynamic molecular assembly as the defining structural feature governing Mg2+ movement across cellular membranes in humans.
The journal officially registered the peer-reviewed paper under the digital object identifier 10.1016/j.cell.2026.06.039. According to the published findings, the human CNNM4 protein operates through a dynamic dimer-of-dimers configuration that directly enables and regulates the physical transport pathway of Mg2+ ions.
The findings clarify the biological architecture of human CNNM4, but Cell did not state whether this dynamic dimer-of-dimers arrangement exists in other proteins across the broader CNNM family. The journal did not disclose whether external physiological conditions or cellular metabolic changes affect the stability of the dynamic dimer-of-dimers structural model during active Mg2+ transfer.
Therapeutic possibilities and practical medical applications were not detailed in the journal output. Cell did not disclose whether pharmaceutical compounds can target or alter the dynamic dimer-of-dimers mechanism, nor did the publication state whether modifying human CNNM4 transport activity influences specific human biological disorders or cellular functions.
The release on July 24, 2026, marks the formal peer-reviewed publication of the protein architecture discovery in Cell under DOI 10.1016/j.cell.2026.06.039. The journal did not outline specific laboratory techniques used during the structural analysis, nor did Cell list institutional research partners, financial grant support, or prospective project schedules.
